Tag Archives: NATR

Top 10 High Tech Stocks To Buy For 2018

What happened

Genomic Health (NASDAQ:GHDX) closed up 10.2% Tuesday following its announcement of solid fourth-quarter earnings after the bell Monday. The company’s 2017 guidance certainly didn’t hurt investors’ confidence either.

Image source: Getty Images.

So what

Genomic Health delivered 8% more genetic tests in the fourth quarter than it did in Q4 2015. More importantly, product revenue rose even faster — up 10% year over year — as the company was able to get paid for more of its genetic cancer tests from insurers and government programs.

Test sales outside the U.S. were particularly strong, increasing 13% year over year. On a constant-currency basis, the increase would have been an even more impressive 16%.

The rate of growth in the use of Genomic Health’s prostate cancer test is accelerating, with U.S. volume up 29% in Q4 compared to a 16% growth rate for 2016 overall. Unfortunately, the prostate cancer test is still a small revenue contributor for the company since it’s not fully covered by Medicare yet: It added just $3.6 million to the revenue line in the quarter.

Top 10 High Tech Stocks To Buy For 2018: Neovasc Inc.(NVCN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Neovasc Inc. (NASDAQ: NVCN) fell about 21% Wednesday to post a new 52-week low of $0.26 after closing at $0.33 on Tuesday. The 52-week high is $2.12. Volume of about 7.3 million was around 7 times the daily average. The medical device maker had no specific news.

  • [By Lisa Levin] Related NVCN 18 Biggest Mid-Day Losers For Wednesday Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data Boston Scientific closes Neovasc transaction (Seeking Alpha)
    Related BSX Watch These 10 Huge Call Purchases In Monday Trade Wonderful Wearables Get Their Own ETF Boston Scientific closes Neovasc transaction (Seeking Alpha) Gainers
    Neovasc Inc (US) (NASDAQ: NVCN) rose 17.3 percent to $2.65 in pre-market trading after the company reported the close of its $75 million transaction with Boston Scientific Corporation (NYSE: BSX).
    aTyr Pharma Inc (NASDAQ: LIFE) shares rose 12.3 percent to $4.10 in pre-market trading after the company disclosed 'promising' signals in myopathies with Resolaris in exploratory trials.
    Globus Maritime Ltd (NASDAQ: GLBS) shares rose 10.1 percent to $6.90 in pre-market trading after climbing 5.03 percent on Monday.
    Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 9.9 percent to $3.00 in pre-market trading. Aurinia Pharmaceuticals appointed Lorin Jeffry “Jeff” Randall to its board and Chairman of the Audit Committee.
    Ocean Rig UDW Inc. (NASDAQ: ORIG) shares rose 8.7 percent to $2.89 in pre-market trading after surging 19.82 percent on Monday.
    Full House Resorts, Inc. (NASDAQ: FLL) shares rose 5.1 percent to $2.08 in pre-market trading after declining 1.98 percent on Monday.
    Seadrill Ltd (NYSE: SDRL) rose 5.1 percent to $4.13 in pre-market trading after surging 3.15 percent on Monday.
    Noble Corporation (NYSE: NE) rose 5.1 percent to $7.60 in pre-market trading after declining 5.37 percent on Monday.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 5.1 percent to $3.10 in pre-market trading. Arbutus issued additional data from its ARB-1467 Phase II
  • [By Lisa Levin]

    Neovasc Inc (US) (NASDAQ: NVCN) shares were also up, gaining 71 percent to $0.880 following announcement of an agreement with Boston Scientific Corporation (NYSE: BSX).

Top 10 High Tech Stocks To Buy For 2018: Intelligent Content Enterprises Inc. (ICEIF)

Advisors’ Opinion:

  • [By Bryan Murphy]

    In hindsight, June’s news from Intelligent Content Enterprises Inc. (OTCMKTS:ICEIF) should come as no surprise. In May the organization announced it was buying Catch Star Studios LLC for the purpose of creating its own sports-related television shows that would be aired by broadcast as well as online. Now it’s begun creating that television content, following in the footsteps of much bigger original-content creators such as Amazon.com, Inc. (NASDAQ:AMZN) and Netflix, Inc. (NASDAQ:NFLX).

    What might comes as a surprise to existing and potential ICEIF shareholders, however, is how big highly-focused original television programming is now that the lines between the internet and cable television have not only been crossed, but erased.

    May wasn’t just a pivotal month for Intelligent Content Enterprises because it’s when the acquisition of Catch Star Studios was put into motion. May was also the month Interactive Advertising Bureau (IAB) reported some stunning results of a new study about digital video-viewing habits and preferences. The key findings? Regular viewers of original digital video programming in the U.S. have grown from 45 million in 2013 to 63 million, and the advertisements displayed via a digital broadcast of such programming are liked and remembered by far more viewers than they are when part of a conventional cable television broadcast.

    Said another way as far as advertisers are concerned, the world wide web is the new cable television. That’s not to say cable television has become irrelevant. Savvy content makers are now doing both, while also making a point of creating their own customized content now that the fight for viewers has gotten brutal.

    Take Netflix as an example. It has a pair of smash hits with its self-produced ‘Orange is the New Black’ and ‘House of Cards.’ Amazon.com is getting into the game too, with its ‘Mozart in the Jungle’ recently being awarded two Golden Globes.

    This same paradigm shift h

  • [By Bryan Murphy]

    If there was any doubt that the future of video as a digital medium was here to stay, Twitter Inc (NYSE:TWTR) just wiped that doubt away. It’s going to open up its video-sharing platform to anyone — not just vetted creators with huge followings — and split ad revenue with them. In so doing, it now offers a similar deal (though a more generous deal) that Facebook Inc (NASDAQ:FB) and YouTube also offers video creators.

    It’s just a microcosm of the shape of things to come… or the shape of things as they already are. Last year was the first year internet users spent more time watching videos online than they did engaged in social media, averaging more one hour and sixteen minutes of video viewing per day.

    Perhaps more important, the amount of ad revenue the likes of Facebook, and now Twitter, generate via online video is small, but growing very fast. The total ad spend allocated for digital video has jumped from 2.4% in 2013 to 4.4% today, and that’s expected to double again in two years.

    Yet, for as much revenue as online video can drive and as big as it’s gotten, the ad-display technology remains alarmingly inelegant, even or veteran players like YouTube and Facebook. This clunky display of ads — and Twitter will likely keep it clunky, at least initially — increasingly makes a company called Intelligent Content Enterprises Inc (OTCMKTS:ICEIF) not just well-positioned, but a potential acquisition target.

    Intelligent Content Enterprises has developed a tool called Clix Video(tm), which the company described as a way to enable “digital and mobile viewers to instantaneously connect to web and mobile sites by clicking on custom interactive tags within the video broadcasts to make social media connections, to review extra and exclusive content and make online and mobile purchases directly via the video broadcast providing a richer, deeper consumer experience related to the video content. “

    In English, it just means Clix Vide

  • [By James E. Brumley]

    In May of this year, at the annual Collision Conference, advertising and media executives of the world’s biggest traffic-oriented (and ad-supported) websites asked themselves a crucial question: How do we save online advertising from itself?

    The question itself is a reflection of the new reality of the internet…. it’s become so big, so full, so cross-border, so competitive, and so promotional that it’s become an unwieldy mess. Twenty years ago, click-through rates were greater than 40%. Now they’re a mere 0.6%, as consumers (1) are saturated by marketing messages, and (2) have largely learned that ads don’t lead them to a product or service they care about. Digital advertising simply isn’t what it used to be.

    While the answer to the question “how can digital advertising be saved?” is a complex one, a company called Intelligent Content Enterprises Inc. (OTCMKTS:ICEIF) addresses at least one aspect of the question, by doing what the web’s capitalists have failed to figure out how to do well. What’s that? ICEIF understands that an ad has to be relevant to a user no matter where that user is, and that to see an ad at all, a user has to be able to read the web’s content in his or her native language.

    Intelligent Content Enterprises, through its Digital Widget Factory website www.digiwidgy.com, has tackled the aforementioned issue head-on, creating a rich website with a built-in translation tool which displays advertisements and offers unique to that reader’s location, and delivers that marketing message in his or her native language.

    It may sound like a lot of work at first glance. But, it’s worth it.

    Digital industry research outfit Common Sense Advisory reports that of the more than 3 billion internet users worldwide, approximately 73% — 2.2 Billion people — are browsing the web in a language other than English. That’s quite a disparity from the fact that more than 50% of the content on the web is na

Top 10 High Tech Stocks To Buy For 2018: Nature's Sunshine Products, Inc.(NATR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

Top 10 High Tech Stocks To Buy For 2018: Carlsberg A/S (CABGY)

Advisors’ Opinion:

  • [By Mark Fritz]

    Price Target: $124.

    Heineken N.V. (ADR) (OTC: HINKY): Hold.
    Price Target: 82.30 euros.

    Carlsberg A/S (ADR) (OTC: CABGY): Hold.
    Price Target: 652 krones.

    Distillers

Top 10 High Tech Stocks To Buy For 2018: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

Top 10 High Tech Stocks To Buy For 2018: Concho Resources Inc.(CXO)

Advisors’ Opinion:

  • [By Paul Ausick]

    Concho Resources Inc. (NYSE: CXO) is also rated a Hold with a higher price target of $150. For 2017, Jefferies raised its EPS estimate from $0.33 to $1.32, and for 2018 the estimate was lifted from $2.91 to $3.50. The stock closed at $132.41 on Friday, in a 52-week range of $94.26 to $147.55, and the consensus 12-month target is $167.46.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was Concho Resources Inc. (NYSE: CXO) which traded down about 7% at $140.01. The stocks 52-week range is $106.73 to $162.91. Volume was about 3 million compared to the daily average volume of 1.5 million.

  • [By Ben Levisohn]

    Lear also sees strong “upside potential” forConcho Resources (CXO), Pioneer Natural Resources (PXD) and Newfield Exploration (NFX) as well performance improves in the Permian/STACK, and also writes positively on Devon Energy (DVN).

Top 10 High Tech Stocks To Buy For 2018: Scana Corporation(SCG)

Advisors’ Opinion:

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was SCANA Corp. (NYSE: SCG) which traded down roughly 5% at $41.13. The stocks 52-week range is $37.10 to $71.28. Volume was 3.5 million, compared with the daily average of 3 million shares.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was SCANA Corp. (NYSE: SCG) which traded down over 6% at $42.38. The stocks 52-week range is $41.15 to $74.99. Volume was over 3.5 million versus the daily average of 2.2 million shares.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was SCANA Corp. (NYSE: SCG) which rose over 22% to $47.71. The stocks 52-week range is $37.10 to $73.81. Volume was about 19 million compared to its average volume of 2 million.

Top 10 High Tech Stocks To Buy For 2018: Warren Resources Inc.(WRES)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Warren Resources, Inc. (NASDAQ: WRES) were down 31 percent to $0.0656. Warren Resources filed for Chapter 11 bankruptcy.

    Gogo Inc (NASDAQ: GOGO) was down, falling around 15 percent to $9.40 after the company announced it has reached an agreement with American Airlines Group Inc (NASDAQ: AAL) to “continue to provide service on a meaningful portion of the American fleet currently served by Gogo.” Investors heavily sold off the stock as the company’s announcement implies it lost some orders to its main competitor, ViaSat, Inc. (NASDAQ: VSAT).

Top 10 High Tech Stocks To Buy For 2018: SPDR Wells Fargo Preferred Stock ETF (PSK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    DWFI holds five other SSgA fixed income ETFs, including the SPDR Wells Fargo Preferred Stock ETF (NYSE: PSK). PSK is DWFI's largest holding at a weight of 25.2 percent. DWFI's second-largest holding is an allocation of almost 25 percent to the SPDR Nuveen Barclays Municipal Bond ETF (NYSE: TFI).

Top 10 High Tech Stocks To Buy For 2018: Snyder's-Lance, Inc.(LNCE)

Advisors’ Opinion:

  • [By Monica Gerson]

    Snyder’s-Lance Inc (NASDAQ: LNCE) is estimated to report its quarterly earnings at $0.23 per share on revenue of $470.33 million.

    Examworks Group, Inc. (NYSE: EXAM) is projected to post its quarterly earnings at $0.08 per share on revenue of $217.47 million.

Top 10 Bank Stocks To Buy For 2018

Lancaster, PA, based Investment company Fulton Bank, N.A. buys Canadian Imperial Bank of Commerce, AstraZeneca PLC, Occidental Petroleum Corp, iShares U.S. Preferred Stock ETF, Cummins Inc, Public Storage, Dominion Energy Inc, Total SA, Royal Dutch Shell PLC, British American Tobacco PLC, sells McDonald’s Corp, AbbVie Inc, Sanofi SA, Consolidated Edison Inc, WisdomTree Europe Hedged Equity Fund during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, Fulton Bank, N.A.. As of 2017-12-31, Fulton Bank, N.A. owns 354 stocks with a total value of $558 million. These are the details of the buys and sells.

New Purchases: PFF, RDS.A, TECK, TKC, CEO, APTV, BIDU, ALK, AVY, PX, Added Positions: CM, AZN, OXY, CMI, PSA, BTI, D, IBM, TOT, AMGN, Reduced Positions: MCD, ABBV, SNY, IWF, ED, MRK, HEDJ, MO, IWD, SO, Sold Out: CHL, VWDRY, GBOOY, CIGI, COL, PINC, DVMT, PHG, OGE, EVHC,

For the details of Fulton Bank, N.A.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Fulton+Bank%2C+N.A.

Top 10 Bank Stocks To Buy For 2018: Nature's Sunshine Products, Inc.(NATR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

Top 10 Bank Stocks To Buy For 2018: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Cramer was bearish on Prudential (PRU) , Advanced Semiconductor Engineering (ASX) and ZTO Express (ZTO) .

    Read more of Cramer’s comments about the stocks in the Lightning Round.

  • [By WWW.MONEYSHOW.COM]

    Prudential Financial (PRU) is also a major provider of asset management and retirement services. It focuses is on fixed income, a major liability during the past eight years of ultra-low interest rates.

  • [By Chuck Saletta]

    Prudential Financial (NYSE:PRU) has long had the Rock of Gibraltar as its corporate symbol, representing its solid financial position. With more cash and equivalents than debt on its balance sheet, and a total cash hoard of over $49 billion, Prudential still looks set up to handle some downright awful insurable losses. That’s its “Rock of Gibraltar” strength showing through.

Top 10 Bank Stocks To Buy For 2018: Paragon Offshore plc (PGNPQ)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Paragon Offshore’s (OTCPK:PGNPQ) former management’s audacious efforts to omit parts of the senior secured lenders by deeming them unimpaired and instead pay out the majority of the company’s cash to junior unsecured bondholders by presenting a set of entirely unrealistic business forecasts to the court. Fortunately, in case of Paragon Offshore, the bankruptcy judge recognized the framing and accordingly denied confirmation of the company’s plan of reorganization, effectively sending Paragon Offshore back to the drawing board. Consequently, management was ousted after the failure. I have covered the Paragon Offshore saga in a series of articles over the past few quarters, so interested investors might want to take a look at this highly fascinating and still evolving case study.

  • [By SEEKINGALPHA.COM]

    With even brand new rigs struggling to find work, the jig was soon up for owners of old equipment, like Paragon Offshore (OTCPK:PGNPQ), which is currently undergoing its second debt restructuring in less than three years of independent existence. Likewise, drillers with a fondness for aggressive use of debt were soon in trouble, most notably, former high-flier Seadrill (SDRL) and its little brother North Atlantic Drilling (NADL), which will no doubt file for restructuring within months. As a consequence of the crisis, the OSD industry now has a number of participants without a large debt burden, either new entrants like Borr Drilling, or established competitors that have had debt reduced in a restructuring, such as Ocean Rig (ORIG), to be followed within this year by others, almost certainly including each of SDRL, NADL, and Pacific Drilling (PACD).

Top 10 Bank Stocks To Buy For 2018: Itron Inc.(ITRI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Silver Spring Networks Inc (NYSE: SSNI) got a boost, shooting up 24 percent to $16.11. Itron, Inc. (NASDAQ: ITRI) announced plans to acquire Silver Spring Networks for $16.25 per share.

Top 10 Bank Stocks To Buy For 2018: Rigel Pharmaceuticals Inc.(RIGL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares dropped 22 percent to $2.52 after the company reported results from the second FIT Phase 3 study for fostamatinib. The company disclosed that the study did not meet primary endpoint.

Top 10 Bank Stocks To Buy For 2018: Cheniere Energy, Inc.(LNG)

Advisors’ Opinion:

  • [By Craig Jones]

    Pete Najarian noticed that somebody bought 17,000 contracts of the July 55 calls in Cheniere Energy, Inc.(NYSE: LNG) for $0.60. He followed the trade and he is planning to hold it until expiration. The trade breaks even at $55.60 or 9.90 percent higher.

  • [By Brian Feroldi, Chuck Saletta, Tyler Crowe, Jason Hall, and Jordan Wathen]

    With that in mind, we asked a team of Fools each to highlight a stock that a billionaire investor has been selling recently. Read on to see why they chose Cheniere Energy (NYSEMKT:LNG), Activision Blizzard (NASDAQ:ATVI), Suncor Energy (NYSE:SU), MGIC Investment Corporation (NYSE:MTG), and Extended Stay America (NYSE:STAY).

  • [By Manikandan Raman]

    Bays said the momentum would boost fortunes for projects like Cheniere Energy, Inc. (NYSE: LNG)’s Corpus Christi, Liquefied Natural Gas Ltd (ASX:LNG)’s Magnolia, and Tellurian Inc (NASDAQ: TELL)’s Driftwood LNG project, among others.

Top 10 Bank Stocks To Buy For 2018: Magal Security Systems Ltd.(MAGS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, industrial shares fell by 0.04 percent. Meanwhile, top losers in the sector included Unilever N.V. (ADR) (NYSE: UN), down 8 percent, and Magal Security Systems Ltd. (USA) (NASDAQ: MAGS), down 6 percent.

  • [By Peter Graham]

    Israel based small capMagal Security Systems Ltd (NASDAQ: MAGS)was established in 1965 as a branch of the Israeli Aerospace Industry focused on developing smart fences for security. It was floated and privatized15years later and hadanIPO on NASDAQ on 1993. Today, Magal Security Systems is a leading international provider of solutions and products for physical and video security solutions, as well as site management. MAGS offers comprehensive integrated solutions for critical sites, managed by Fortis4G the Companys4th generation, cutting-edge PSIM (Physical Security Information Management system). The solutions leveragea broad portfolio of homegrown PIDS (Perimeter Intrusion Detection Systems), advanced VMS (Video Management Software) with native IVA (Intelligent Video Analytics) Security solutions.

  • [By WWW.MONEYSHOW.COM]

    Magal Security Systems (MAGS) is an Israeli company whose stock trades in the US. The company specializes in “smart fences” that protect large geographic areas, power plants, military bases, prisons, and building complexes against unwanted intrusions.

Top 10 Bank Stocks To Buy For 2018: Vanguard Short-Term Government ETF(VGSH)

Advisors’ Opinion:

  • [By Donald van Deventer]

    Shorter-duration Treasury Exchange-Traded Funds: (SHY), (SHV), (IEI), (BIL), (TUZ), (FIVZ), (DTUL), (VGSH), (DTUS), (DFVS), (DFVL), (SST), (ISTB), (TBZ).

Top 10 Bank Stocks To Buy For 2018: Nustar Energy L.P.(NS)

Advisors’ Opinion:

  • [By Roberto Pedone]

    One technology player that insiders are active in here is Jive Software (NS), which provides a social business software platform to businesses, government agencies, and other enterprises. Insiders are buying this stock into massive weakness, since shares are down sharply by 43% so far in 2014.

     

    Jive Software has a market cap of $446 million and an enterprise value of $365 million. This stock trades at a fair valuation, with a price-to-sales of 2.68 and a price-to-book of 5.67. Its estimated growth rate for this year is 45.5%, and for next year it’s pegged at 30%. This is a cash-rich company, since the total cash position on its balance sheet is $98.18 million and its total debt is $6.60 million.

     

    A director just bought 260,819 shares, or about $1.71 million worth of stock, at $6.53 to $6.60 per share.

     

    From a technical perspective, JIVE is currently trending just above its 50-day moving average and below its 200-day moving average, which is neutral trendwise. This stock recently pulled back off its short-term high of $7.14 a share with heavy downside volume flows. That drop has now pushed the stock to right above its 50-day moving average at $6.10 a share.

    If you’re bullish on JIVE, then I would look for long-biased trades as long as this stock is trending above its 50-day at $6.10 a share and then once it breaks out above some key near-term overhead resistance levels at $7.14 a share to its 200-day moving average of $7.43 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 557,678 shares. If that breakout triggers soon, then JIVE will set up to re-test or possibly take out its next major overhead resistance levels $8.50 to $9 a share, or even $9.50 to $10 a share.

    Must Read: 10 Stocks George Soros Is Buying

Top 10 Bank Stocks To Buy For 2018: Kinross Gold Corporation(KGC)

Advisors’ Opinion:

  • [By Scott Levine]

    Instead of the P/E, therefore, we’ll consider the companies on the basis of price-to-cash from operations on a trailing-12-month (TTM) basis. Cash flow, after all, is one thing management can’t be massaged.

    CompanyPrice-to-CFO Per Share (TTM)

    Eldorado Gold 17.9
    Goldcorp(NYSE:GG) 15.3
    Agnico Eagle Mines 11.2
    Barrick Gold 7.9
    Newmont Mining 6.2
    IAMGOLD (NYSE:IAG) 4.6
    Yamana Gold (NYSE:AUY) 3.6
    Kinross Gold (NYSE:KGC) 3.6

    Data Source: YCharts.

  • [By Wayne Duggan]

    Citi also placed Neutral ratings on Goldcorp Inc. (USA) (NYSE: GG), Kinross Gold Corporation (USA) (NYSE: KGC) and Silver Standard Resources Inc. (USA) (NASDAQ: SSRI).

  • [By Monica Gerson]

    Kinross Gold Corporation (USA) (NYSE: KGC) is projected to post a quarterly loss at $0.01 per share on revenue of $808.09 million.

    Crocs, Inc. (NASDAQ: CROX) is expected to report its quarterly earnings at $0.05 per share on revenue of $265.90 million.

  • [By Ben Levisohn]

    Given revised commodity deck forecasts (particularly for Steel and Gold) and improved Balance Sheet health (Steels, Precious and Industrials Metals) we are upgrading our ratings on several stocks in our coverage. We generally favor companies that have already initiated specific self-help, have low-cost assets and are less exposed to China supply and demand dynamics. In Steels, we have increased our rating from Hold to Buy on Nucor (NUE) and from Sell to Hold on US Steel. We have also upgraded Kinross Gold (KGC) to a Hold on valuation…On higher-than-peer valuations, we reiterate Sell-rated Coeur Mining (CDE), Franco-Nevada (FNV), Goldcorp (GG), Teck Resources (TCK) and highly leveraged AK Steel given preference to issue further equity if possible.

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Kinross Gold Corporation (USA) (NYSE: KGC) and Yamana Gold Inc. (USA) (NYSE: AUY).

Top 5 Low Price Stocks To Own Right Now

Peyto (OTCPK:PEYUF) is a Canadian E&P company whose production profile is dominated by dry gas (92%). With the low price of natural gas, it has been a tough couple of years for Peyto’s shareholders. That said, the company has maintained its dividend payout through the commodity price downturn. Recently natural gas prices have recovered from their lows, but Peyto’s stock has not kept pace. In fact, it’s gone the other direction:

Click to enlarge

As the chart above show, the stock is down ~13% over the past three months as natural gas – as measure by both the Henry Hub and AECO indexes – has rallied sharply with significant winter withdrawals and forecasts that additional cold weather is on the way:

Top 5 Low Price Stocks To Own Right Now: Ascent Capital Group, Inc.(ASCMA)

Advisors’ Opinion:

  • [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]

    Both of these stocks are overlooked, undervalued, and cash flow machines. The companies are Ascent Capital Group (ASCMA) and Covanta Holdings (CVA).

  • [By Lisa Levin]

    Tuesday afternoon, the industrial sector proved to be a source of strength for the market. Leading the sector was strength from NL Industries Inc (NYSE: NL) and Ascent Capital Group Inc (NASDAQ: ASCMA).

Top 5 Low Price Stocks To Own Right Now: Roper Technologies, Inc.(ROP)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Aside from Outperform-rated Roper Technologies (ROP) SaaS platforms, which account for over +50% of earnings today, GEs Digital business strategy is the most ambitious ramp within the industrials sector. GE has made a bold bet on its game-changing Predix operating system for the Industrial IoT, which was launched in Feb-2016

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

  • [By Monica Gerson]

    Analysts are expecting Roper Technologies Inc (NYSE: ROP) to have earned $1.46 per share on revenue of $895.87 million in the latest quarter. Roper Technologies shares declined 0.05 percent to close at $178.63 on Friday.

  • [By Monica Gerson]

    Roper Technologies Inc (NYSE: ROP) is projected to report its quarterly earnings at $1.46 per share on revenue of $895.87 million.

    Express Scripts Holding Company (NASDAQ: ESRX) is expected to post its quarterly earnings at $1.22 per share on revenue of $25.20 billion.

Top 5 Low Price Stocks To Own Right Now: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

Top 5 Low Price Stocks To Own Right Now: FORM Holdings (FH)

Advisors’ Opinion:

  • [By Matthew Briar]

    Looking for a quick, money-making trading idea? Put FORM Holdings Corp. (NASDAQ:FH) on your watchlist, if not yet in your portfolio. FH shares are knocking on the door of a breakout move, and one more nudge could do the trick.

    There are a couple of factors in play here. One of the is the converging wedge pattern that’s developed after the October-December finally stabilized. The upper boundary of that wedge at $2.40 has been tested several times since late last year, but FORM Holdings could never get past the hurdle. At the same time, several key moving average lines seem to be acting as support — even if unevenly — keeping FH positioned well for a breakout effort.

Top 5 Low Price Stocks To Own Right Now: Nature's Sunshine Products, Inc.(NATR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

gold investment

BMO Capital Markets analyst M. IanSomaiya and team take a look at the “clinical readouts through the end of 2016″ and find upside catalysts for Celgene (CELG), Amgen (AMGN), Biogen (BIIB), and Gilead Sciences (GILD) They explain:

Paulo Fridman/Bloomberg News

Celgene: We believe positive data from the mongersen Phase 2 endoscopy study should move shares higher if the trial demonstrates a benefit on CDAI (the Phase 3 primary endpoint) in line with the IGON-1 Phase 2 trial and endoscopic improvement correlated with therapy duration.

Amgen: We believe positive data from the GLAGOV vascular imaging trial could provide a positive read-through to the success of the ongoing FOURIER CV outcomes trial (data expected 2017).

Biogen: We believe positive titration data from the ongoing Phase 1b study of aducanumab in Alzheimer’s disease could de-risk the ongoing Phase 3 trials.

gold investment: Nature's Sunshine Products, Inc.(NATR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

gold investment: CME Group Inc.(CME)

Advisors’ Opinion:

  • [By ]

    Market Exchanges like the CME Group (Nasdaq: CME) have just started allowing trading in bitcoin futures and could attract an entirely new type of retail user as well as allowing institutional clients access to the bitcoin theme. Exchanges make their money on transactional volume, so a bursting of the bitcoin bubble wouldn’t necessarily mean weakness for shares.

  • [By David Zeiler]

    Bitcoin futures trading started at the CBOE Global Markets Inc. (Nasdaq: CBOE) on Dec. 10 and on the much larger CME Group Inc. (Nasdaq: CME) on Dec. 18. Nasdaq Inc. (Nasdaq: NDAQ) plans to begin trading Bitcoin futures in the first half of next year.

gold investment: AbbVie Inc.(ABBV)

Advisors’ Opinion:

  • [By J.B. Maverick]

     The pharmaceutical and health care sectors are generally less vulnerable to volatile and cyclical market moves, and may be one of the safer bets in 2016. Major drug manufacturer AbbVie, Inc. (NYSE: ABBV) has performed well for investors, and there are plenty of reasons to believe it will continue to do so. It is difficult to find a stock that shows a return on equity (ROE) of 59.3%, more than double the industry average of 23.3%. In addition, the stock’s dividend yield of 3.76% is well above the S&P 500 average, and the company has stated its firm commitment to return income to investors with a growing dividend payout. With successful drugs such as Humira and Imbruvica, and promising new ones in the company’s development pipeline, AbbVie has experienced revenue growth from $14 billion to $23 billion since 2009, and analysts project earnings per share (EPS) in the neighborhood of $5 for 2016, which represents an increase of 17%.

  • [By WWW.MONEYSHOW.COM]

    AbbVie (ABBV) reported third quarter 2016 net sales increased a healthy 8% to $6.4 billion with net income increasing 29% to $1.6 billion and EPS increasing 31% to $.97.

  • [By Keith Speights, Brian Stoffel, and George Budwell]

    Healthcare is changing rapidly. Which companies will emerge as the huge winners with these major changes? We asked three of our healthcare contributors to weigh in on the subject. Here’s whyAbbVie (NYSE:ABBV),Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG), Johnson & Johnson (NYSE:JNJ), and Veeva Systems (NYSE:VEEV) could represent bold bets on the future of healthcare.

  • [By Jim Robertson]

    That’s why its worth pointing out that just yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announced the appointment of Tracy Rockney, J.D. to the position of Senior Regulatory Advisor. In addition to being the Co-Founder & Chief Operating Officer of OneSource Regulatory, a regulatory consulting firm, Rockney was previously:

    From May 2010 to May 2015, she was the VP, Regulatory Affairs at AbbVie Inc (NYSE: ABBV) leading the executive functions related to regulatory policy and intelligence. From August 1993 to January 2005, she held positions of increasing responsibility with Pfizer Inc (NYSE: PFE), formerly Wyeth.  From January 2005 to April 2010, she held positions with Shire PLC (NASDAQ: SHPG), including serving as Senior Director, Regulatory Affairs. This included responsibilities as Therapeutic Area Head for Shire’s Gastrointestinal Business Unit, Regulatory Advertising & Promotion and CMC. Rockney led the regulatory team and negotiations with the FDA for LIALDA which are part of the drug class of aminosalicylates that are now part of the clinical standard-of-care for treating inflammatory bowel disease. LIALDA™ was found to be effective in Phase 3 trials for inducing remission of active mild-to-moderate ulcerative colitis after eight weeks of treatment. LIALDA™ (also now marketed as Mezavant®) had 2016 U.S. sales of $714 million – up 16% relative to 2015 sales.

    Rockney’s work for Shire is of particular interest to Vitality Biopharma which has developed a new class of cannabinoid prodrugs (medications or compounds that, after administration, are converted within the body into a pharmacologically active drug), known as cannabosides, which upon ingestion can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. Cannabosides could provide therapeutic benefits for infl

gold investment: Lifetime Brands Inc.(LCUT)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Monday, cyclical consumer goods & services shares gained by 0.41 percent. Top gainers in the sector included Kandi Technologies Group Inc (NASDAQ: KNDI), Starwood Hotels & Resorts Worldwide Inc (NYSE: HOT), and Lifetime Brands Inc (NASDAQ: LCUT).

gold investment: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Chris Lange]

    Immunomedics, Inc. (NASDAQ: IMMU) saw its shares rise after the firm sent out a letter to shareholders imploring them to vote for its director nominees at the upcoming annual stockholders meeting on February 16. The board of directors is making this request because it is currently waging a proxy contest with venBio SelectAdvisor.

gold investment: China Petroleum & Chemical Corporation(SNP)

Advisors’ Opinion:

  • [By Paul Ausick]

    The Permian Basin pipeline project includes an investment by China’s state-controlled China Petroleum & Chemical Corp. (NYSE: SNP), aka Sinopec. Other partners in the project include ArcLight Capital and Freepoint Commodities LLC. The deal also includes an expansion to oil storage facilities in the U.S. Virgin Islands, where recent hurricanes have caused so much damage. The project still requires approval from both countries governments.’

Hot Value Stocks To Buy For 2018

 We've spent a lot of time discussing Steve's big stock market calls of late…   And for good reason… He has been on an absolute tear.   Across his three publications – True Wealth, True Wealth Systems, and True Wealth China Opportunities – readers are currently up double digits or better on most of his broad market recommendations in the U.S., Europe, China, and Japan, among others.   But make no mistake… Steve has continued to find big, contrarian opportunities for his subscribers across the investment world.   For example, in early 2016, Steve alerted subscribers to a huge opportunity in an area of the market most investors had left for dead: the resource sector.   At the time, most commodities were in a brutal bear market. Prices had plunged for nearly five straight years… Most resource stocks had lost 75% of their value or more.

Hot Value Stocks To Buy For 2018: B2Gold Corp(BTG)

Advisors’ Opinion:

  • [By Peter Graham]

    The following mining companies are active in Burkina Faso:

    Semafo Inc (TSE: SMF; OTCMKTS: SEMFF).SEMAFO operates the Mana Mine in Burkina Faso, which includes the high-grade satellite deposit of Siou, and is targeting production start-up of the Boungou Mine in the second half of 2018. SEMAFO’s strategic focus is to maximize shareholder value by effectively managing its existing assets as well as pursuing organic and strategic growth opportunities. SEMAFOs Mana Mine is located 260 kilometers southwest of the capital Ouagadougou. The third-largest mine in the country, it has produced some 1.6 million ounces since its first gold pour in 2008. Since then,the Company hasexpanded the plant four times to a current processing rate of over 7,200 tonnes per day. IAMGOLD Corp (NYSE: IAG). Iamgold has four operating gold mines on three continents with asolid base of strategic assets in North and South America and West Africa that is complemented by development and exploration projects with continued assessment of accretive acquisition opportunities. Iamgold is said to be thelargest private employer in Burkina Faso andhas a high level of exposure in the region with two operating mines in Mali and a mine in northern Burkina Faso near the Mali border. Roxgold Inc (TSE: ROXG; OTCMKTS: ROGFF). Roxgold is a gold mining company with its key asset, the high grade Yaramoko Gold Mine, located in the Hound茅 greenstone region of Burkina Faso, West Africa. The Company declared commercial production on October 1, 2016. The Yaramoko permit covers approximately 196km2 in the Province of Bal茅 in southwestern Burkina Faso. The property is located approximately 200 kilometres southwest from the capital city of Ouagadougou. Yaramoko lies directly south of, and is contiguous to, the SEMAFO Inc property hosting its flagship Mana Gold Mine and lies within the Hounde greenstone belt. Endeavour Mining Corp (TSE: EDV; OTCMKTS: EDVMF). Endeavour is ideally positioned as the majo

  • [By Lisa Levin] Related CXW Trump Or Clinton: Who Would Create More Jobs? The 2016 Economics Nobel Prize Winner's Case Against Private Prisons: Contracts Are The Key Wall Street Breakfast: Trump Takes The White House (Seeking Alpha)
    Related SAEX 20 Biggest Mid-Day Losers For Friday 22 Stocks Moving In Friday's Pre-Market Session SAExploration wins $35M seismic data deal (Seeking Alpha)
    Gainers
    Corrections Corp Of America (NYSE: CXW) shares rose 16.3 percent to $16.50 in pre-market trading following Donald Trump's victory.
    SAExploration Holdings, Inc. (NASDAQ: SAEX) shares rose 15.4 percent to $7.26 in pre-market trading after the company reported a new $35 million deep water ocean-bottom marine project award.
    The GEO Group Inc (NYSE: GEO) shares rose 12.9 percent to $26.95 in pre-market trading following Donald Trump's victory.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 12.3 percent to $7.40 in pre-market trading after gaining 0.30 percent on Tuesday.
    Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) rose 11.7 percent to $10.35 in pre-market trading. Ariad Pharmaceuticals disclosed that its Phase 1/2 trial data on investigational drug brigatinib were published in The Lancet Oncology.
    AK Steel Holding Corporation (NYSE: AKS) rose 11.2 percent to $6.75 in pre-market trading after gaining 3.23 percent on Tuesday.
    Pretium Resources Inc (NYSE: PVG) rose 11 percent to $10.50 in pre-market trading after declining 1.66 percent on Tuesday.
    First Majestic Silver Corp (NYSE: AG) rose 9.3 percent to $8.90 in the pre-market trading session. First Majestic reported Q3 earnings of $0.07 per share on revenue of $79.3 million. Silver futures gained 2.2 percent to $18.77 an ounce.
    Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) rose 9.2 percent to
  • [By Monica Gerson]

    B2Gold Corp (NYSE: BTG) is estimated to post its quarterly earnings at $0.00 per share on revenue of $135.84 million.

    Astro-Med, Inc. (NASDAQ: ALOT) is projected to post its quarterly earnings at $0.21 per share on revenue of $25.50 million.

Hot Value Stocks To Buy For 2018: Nature's Sunshine Products, Inc.(NATR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

Hot Value Stocks To Buy For 2018: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Jim Robertson]

    The earnings report summarized the following recent milestones:

    The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.

    Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.

  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

  • [By Teresa Rivas]

    Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.

    Pixabay

    As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.

    Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:

    While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.

    Jazz shares are up 8.9% to $153.2o at recent check.

  • [By Benzinga News Desk]

    On Wednesday, just 24 hours after Amazon announced its first major sports deal — tying up with the NFL to stream 10 Thursday night games — Alphabet Inc (NASDAQ: GOOGL) laid claim to viewers’ credit cards by debuting YouTube TV, a bundle of 50 major television channels for $35 per month: Link

    ECONOMIC DATA
    March 2017 US Challenger layoffs report 43,310 vs 36,975
    Initial Jobless Claims for Mar 31 234.0K vs 250.0K estimate; Continuing Claims for Mar 24 2.03M vs 2.04M estimate.
    San Francisco Federal Reserve Bank President John Williams is set to speak in Frankfurt at 9:30 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks is schedule for release at 10:30 a.m. ET.
    Data on money supply for the recent week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    Goldman Sachs initiated Advanced Micro Devices (NASDAQ: AMD) at Sell
    JMP Securities upgraded NetApp (NASDAQ: NTAP) from Market Underperform to Market Perform
    PiperJaffray upgraded Abiomed (NASDAQ: ABMD) from Neutral to Overweight
    Deutsche Bank downgraded T-Mobile (NASDAQ: TMUS) from Buy to Hold
    Mizuho downgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) from Buy to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.